Labcorp Holdings Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.95B | $13.01B | $12.16B | $11.86B | $13.14B | $13.98B | $11.55B | $11.33B |
| Cost of Revenue | $9.94B | $9.38B | $8.80B | $8.16B | $8.14B | $9.03B | $8.30B | $8.16B |
| Gross Profit | $4.01B | $3.62B | $3.36B | $3.71B | $4.99B | $4.95B | $3.25B | $3.18B |
| Gross Margin | 28.8% | 27.9% | 27.7% | 31.3% | 38.0% | 35.4% | 28.1% | 28.0% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.22B | $2.23B | $2.02B | $1.76B | $1.69B | $1.73B | $1.62B | $1.57B |
| Operating Income | $1.38B | $1.09B | $725.6M | $1.44B | $3.05B | $2.45B | $1.33B | $1.33B |
| Operating Margin | 9.9% | 8.4% | 6.0% | 12.1% | 23.2% | 17.5% | 11.5% | 11.7% |
| Interest Expense | $224.1M | $208.3M | $199.6M | $179.8M | $211.8M | $207.4M | $240.7M | $244.2M |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | $229.8M | $212.4M | $188.5M | $233.9M | $690.0M | $662.1M | $280.0M | $384.4M |
| Net Income | $876.5M | $746.0M | $418.0M | $1.28B | $2.38B | $1.56B | $823.8M | $883.7M |
| Net Margin | 6.3% | 5.7% | 3.4% | 10.8% | 18.1% | 11.1% | 7.1% | 7.8% |
| EPS (Basic) | $10.54 | $8.89 | $4.80 | $14.05 | $24.60 | $15.99 | $8.42 | $8.71 |
| EPS (Diluted) | $10.46 | $8.84 | $4.77 | $13.97 | $24.39 | $15.88 | $8.35 | $8.61 |
| Shares Outstanding (Basic) | 83.2M | 83.9M | 87.1M | 91.1M | 96.7M | 97.3M | 97.9M | 101.4M |
| Shares Outstanding (Diluted) | 83.8M | 84.4M | 87.6M | 91.6M | 97.5M | 98.0M | 98.6M | 102.6M |
| Dividends Per Share | $2.88 | $2.88 | $2.88 | $2.16 | — | — | — | — |